نتائج البحث - "Günthard, Hf"

المساهمون: Swiss HIV Cohort Study, Aebi-Popp, K., Anagnostopoulos, A., Battegay, M., Bernasconi, E., Böni, J., Braun, D.L., Bucher, H.C., Calmy, A., Cavassini, M., Ciuffi, A., Dollenmaier, G., Egger, M., Elzi, L., Fehr, J., Fellay, J., Furrer, H., Fux, C.A., Günthard, H.F., Haerry, D., Hasse, B., Hirsch, H.H., Hoffmann, M., Hösli, I., Huber, M., Kahlert, C.R., Kaiser, L., Keiser, O., Klimkait, T., Kouyos, R.D., Kovari, H., Ledergerber, B., Martinetti, G., Martinez de Tejada, B., Marzolini, C., Metzner, K.J., Müller, N., Nicca, D., Paioni, P., Pantaleo, G., Perreau, M., Rauch, A., Rudin, C., Scherrer, A.U., Schmid, P., Speck, R., Stöckle, M., Tarr, P., Trkola, A., Vernazza, P., Wandeler, G., Weber, R., Yerly, S.

المصدر: Clinical microbiology and infection, vol. 28, no. 4, pp. 611.e1-611.e7

مصطلحات موضوعية: Microbiology (medical), business.industry, Hepatitis C virus, HIV Infections, Hepacivirus, General Medicine, CD8-Positive T-Lymphocytes, Hepatitis C, Chronic, medicine.disease_cause, Acquired immune system, Antiviral Agents, Hepatitis C, Virus, Blood cell, Infectious Diseases, medicine.anatomical_structure, Immune system, Interquartile range, Immunity, Immunology, Humans, Cytotoxic T cell, Medicine, Antiviral Agents/therapeutic use, HIV Infections/complications, HIV Infections/drug therapy, Hepatitis C/complications, Hepatitis C/drug therapy, Hepatitis C, Chronic/drug therapy, Adaptive immunity, Direct-acting antiviral therapy, Human immunodeficiency virus, Innate immunity, Mass cytometry, Single cell, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c30428717530d82d30ac275019f4d5
https://doi.org/10.1016/j.cmi.2021.08.018

6

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment

المساهمون: Infectious diseases, APH - Aging & Later Life, Mocroft, A., Neesgard, B., Zangerle, R., Rieger, A., Castagna, A., Spagnuolo, V., Antinori, A., Lampe, F. C., Youle, M., Vehreschild, J. J., Mussini, C., Borghi, V., Begovac, J., Duvivier, C., Gunthard, H. F., Rauch, A., Tiraboschi, J., Chkhartishvili, N., Bolokadze, N., Wit, F., Wasmuth, J. C., De Wit, S., Necsoi, C., Pradier, C., Svedhem, V., Stephan, C., Petoumenos, K., Garges, H., Rogatto, F., Peters, L., Ryom, L.

المصدر: HIV medicine, 21(9), 599-606. Wiley-Blackwell
Mocroft, A (2020). Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment. HIV medicine, 21(9), pp. 599-606. Wiley 10.1111/hiv.12888 <http://dx.doi.org/10.1111/hiv.12888>

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, International Cooperation, protease inhibitors, Integrase inhibitor, HIV Infections, Logistic regression, law.invention, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Acquired immunodeficiency syndrome (AIDS), Randomized controlled trial, law, Internal medicine, medicine, Humans, Pharmacology (medical), Protease inhibitor (pharmacology), 030212 general & internal medicine, HIV Integrase Inhibitors, antiretroviral naïve, Reverse-transcriptase inhibitor, business.industry, Health Policy, Middle Aged, Viral Load, medicine.disease, nonnucleoside reverse transcriptase inhibitors, 030112 virology, CD4 Lymphocyte Count, Infectious Diseases, Logistic Models, Treatment Outcome, integrase inhibitors, Cohort, HIV-1, RNA, Viral, Reverse Transcriptase Inhibitors, Female, business, Viral load, medicine.drug